Document:

Exhibit

                                                                                                                                             Exhibit 10.34
    
                                                        

September 28, 2016                                        

Scott Fenoglio - Hand Delivered

Re: Promotion    

Dear Scott:

Thank you for your continued service to Bonanza Creek Energy, Inc. (the “Company”).  The Company is pleased to confirm your promotion to the position of Senior Vice President, Finance & Planning, reporting to me, effective October 1, 2016.  Your direct reports will be: Wade Jaques, Scott Landreth, and John Wren.

Here are further details related to this promotion:

		
	•
	An annual salary of $275,000 to be paid on a bi-weekly basis, subject to all withholdings, taxes, and deductions;

		
	•
	Continued participation in the Company’s Short Term Incentive Program (the “STIP”) administered at the discretion of the Compensation Committee of the Board of Directors of the Company.  The STIP has been designed to supplement your base salary and provide a year-over-year short term incentive cash bonus payment opportunity if and when the Company meets or exceeds its goals and you meet your individual goals.  We expect that your “target” cash bonus opportunity for 2017 will be equal to 75% of your base salary, based on Company performance achievement as well as individual performance.  Your 2016 cash bonus will be pro-rated to take into account your varied base salary and STIP target levels as Vice President, Planning and your new role as Senior Vice President, Finance & Planning;

		
	•
	Continued participation in the Company’s Executive Change in Control and Severance Plan, as amended (the “Severance Plan”).  Coincident with your promotion, your status under the Severance Plan will change from a Tier 4 Executive to a Tier 3 Executive (as those terms are defined in the Severance Plan);

		
	•
	Continued participation in the Company’s Amended and Restated 2011 Long Term Incentive Program (“LTIP”), subject to the terms and conditions of the LTIP and the award agreement(s) to be entered into thereunder, at the discretion of the Company’s Compensation Committee and Board of Directors;

		
	•
	Continued participation in the Company’s No Tracking Vacation Program; ten (10) days sick leave annually; and eleven (11) paid holidays per year, all in accordance with the Company’s benefits policy;  

		
	•
	Option to participate or continued participation in the Company’s 401(k) Plan, in accordance with such plan; currently the Company provides matching contributions of 6% of W-2 income, which amount may be amended from time to time in accordance with the terms of the 401(k) Plan;

		
	•
	Option to participate or continued participation in the Company’s health insurance plans upon your election subject to the terms and conditions of the plans; and

		
	•
	Option to participate or continued participation in the Company’s flexible benefit plan (Section 125 Plan).

The Board may modify compensation and benefits from time to time in its sole discretion as it deems necessary.  

The terms and conditions of employment set forth in this Employment Letter remain subject to your previously executed Employee Restrictive Covenants, Proprietary Information and Inventions Agreement. You will continue to be expected to abide by the Company’s rules and regulations, as such may be modified by the Company from time to time.  

Nothing in this offer letter is intended or should be construed as a contract of employment or agreement to any specified term of employment.  Your employment with the Company is at-will.  You may terminate your employment with the Company at any time and for any reason whatsoever simply by notifying the Company.  Likewise, the Company may terminate your employment at any time and for any reason whatsoever, with or without cause or advance notice.  

The Company may in the future decide to hire a Chief Financial Officer or a similar executive-level officer.  In such event, you may begin reporting to such a new officer rather than to the President and Chief Executive Officer, and some portion of your authority, duties, or responsibilities may transfer to such officer.  You hereby agree that any such hiring and associated change in your authority, duties, responsibilities, or reporting lines shall not, in and of themselves, constitute or otherwise serve as a basis for a finding of Good Reason (as that term is defined and used under the Severance Plan).

Scott, we would be extremely pleased to have you assume this role for the Company.  Please respond to me with your decision by September 30, 2016.  If you accept the terms of employment outlined in this letter, please execute where indicated below and return to me.  

If you have any questions or need additional information, please feel free to contact me.  I very much look forward to working with you.

                            
/s/ Richard J Carty                            
Richard J. Carty
                      President & CEO
Acknowledged and Agreed:

                
/s/ Scott Fenoglio
Scott Fenoglio
September 28, 2016
DatedExhibit 10.1

 

EQUITY PURCHASE AGREEMENT

 

This Equity Purchase Agreement (the “Agreement”)
is made and entered into as of March 15, 2017 between JAKKS Pacific, Inc., a Delaware corporation (the “Company”),
and Hongkong Meisheng Culture Company Ltd., a company incorporated in Hong Kong (the “Investor”).

 

RECITALS:

 

		A.	The Investor desires to invest to US Dollars (“USD”) 19,311,200.00 (the “Investment Amount”)
in the Company’s Common Stock, par value $.001 per share (“Common Stock”), at a per share purchase price
equal to USD 5.275.

 

NOW, THEREFORE, the Company and the Investor hereby agree as
follows:

 

1. Purchase
and Sale.

 

(A) Subscription. Upon the terms and subject to the
conditions set forth herein, the Investor hereby subscribes for and agrees to purchase, and the Company does hereby agree to sell
to the Investor and deliver to the Investor 3,660,891 shares (the “Shares”) of the Company’s Common Stock
for a per share purchase price equal to USD 5.275 resulting in a total purchase price of USD 19,311,200.00 (the “Purchase
Price”.)

 

(B) Closing and
Payment. The closing of the purchase and sale of the Shares (“Closing”) is subject to the following conditions
(the “Investor Closing Conditions”): the approval of the execution and delivery of this Agreement, the Registration
Rights Agreement and the consummation of transactions contemplated hereby (including the appointment of the Investor’s nominee
Mr. Xiaoqiang Zhao (the “Nominee”) as a member of the Board of Directors of the Company (the “Board”),
provided the Director Background Condition (as hereafter defined) is satisfied) by the shareholders of Meisheng Culture &
Creative Corp., Ltd., the parent company of the Investor (the “Investor Shareholder Approval”). The Investor
will give prompt notice to the Company of the satisfaction of the Investor Closing Conditions. The Closing will occur within three
(3) business days after the date on which the Investor Closing Conditions and the Director Background Condition are satisfied (the
“Closing Date”) and on the Closing Date the Investor will deliver the Purchase Price in USD to the Company by
wire transfer to the account designated by the Company.

 

(C) Share Certificates. Promptly after delivery of the
Purchase Price the Company (but in any event within one (1) business days thereafter) will instruct its transfer agent to issue
certificates to the Investor representing the Shares. The certificates representing the Shares shall have been duly signed and
have endorsed thereon a legend in substantially the following form: “The Shares represented by this Certificate have not
been registered under the Securities Act of 1933, as amended (the “Securities Act”.) They may not be sold,
offered for sale, pledged or hypothecated in the absence of an effective Registration Statement for the Shares under the Securities
Act or an opinion of counsel satisfactory to the Company that such registration is not required.”

 

(D) Registration Rights Agreement. Concurrently with
the Closing, the Investor and the Company shall execute a Registration Rights Agreement in the form annexed (the “Registration
Rights Agreement”.)

 

    	 	1	 

     

    

 

2. Representations
and Warranties of the Investor. The Investor represents and warrants as follows:

 

(A) Federal Securities
Laws Matters. The Investor acknowledges that (i) the Shares have not been registered under the Securities Act of 1933 (the
“Securities Act”); (ii) the Shares must be held indefinitely and the Investor must continue to bear the economic
risk of the investment therein, unless such Shares are subsequently registered under the Securities Act, or an exemption from such
registration (including Rule 144 promulgated under the Securities Act, “Rule 144”) is available; (iii) a restrictive
legend shall be placed on the certificate(s) representing the Shares as set forth above; and (v) a notation shall be made in the
appropriate records of the Company indicating that the Shares are subject to restrictions on transfer.

 

(B)  Investor Status.
(i) The Investor is an “accredited investor” as such term is defined in Rule 501(a) promulgated under the Securities
Act and (ii) (A) the Investor's financial situation is such that the Investor can afford to bear the economic risk of investing
in the Company for an indefinite period of time, (B) the Investor can afford to suffer complete loss of its investment in the Shares,
(C) the Investor's knowledge and experience in financial and business matters are such that the Investor is capable of evaluating
the merits and risks of the Investor's investment in the Shares, and (D) the Investor understands and has taken cognizance of all
the risk factors related to the purchase of the Shares.

 

(C) Due Execution and Delivery. The Investor has duly
executed and delivered this Agreement and has executed, or will execute, the Registration Rights Agreement; this Agreement and,
when executed, the Registration Rights Agreement, constitute legal, valid and binding obligations of the Investor, enforceable
in accordance with their respective terms; and, other than (i) the Investor Shareholder Approval, (ii) any filing and/or disclosure
may be required by the China Securities Regulatory Commission and the stock exchange on which shares of the parent company of
the Investor are listed (the “Securities Filing”) and (iii) filing with relevant Chinese authorities in respect
of overseas investment by a Chinese person (the “Overseas Investment Filing”), no consent, approval, authorization,
order, filing, registration or qualification of or with any court, governmental authority or third person is required to be obtained
by the Investor in connection with the execution and delivery of this Agreement or the Registration Rights Agreement, or the performance
of the Investor's obligations hereunder or thereunder.

 

(D) Purchase Entirely for Own Account. This Agreement
is made with the Investor in reliance upon the Investor’s representation to the Company, which by the Investor’s execution
of this Agreement Investor hereby confirms, that the Shares to be purchased by Investor will be acquired for investment for Investor’s
own account, not as a nominee or agent, and not with a view to the distribution of any part thereof, and that the Investor has
no present intention of selling, granting any participation in, or otherwise distributing the same. By executing this Agreement,
Investor further represents and warrants that the Investor does not have any contract, undertaking, agreement or arrangement with
any Person (as hereafter defined) or any other third party to sell, transfer, pledge or grant participations to such Person to
any other third party, with respect to any of the Shares.

 

    	 	2	 

     

    

 

(E) Certain Transactions. The Investor has not, during
the seven (7) days prior to the date of this Agreement, directly or indirectly traded in the Common Stock or established any hedge
or other position in the Common Stock or any security (other than a broad-based market basket or index) that includes, relates
to or derives any significant part of its value from the Common Stock, that is outstanding on the date of this Agreement and that
is designed to or could reasonably be expected to lead to or result in a direct or indirect sale, offer to sell, solicitation
of offers to buy, disposition of, loan, pledge or grant of any right with respect to the Common Stock or other securities of the
Company by the Investor or any other Person. Such prohibited hedging or other transactions would include, without limitation,
effecting any short sale or having in effect any short position (whether or not such sale or position is against the box and regardless
of when such position was entered into) or any purchase, sale or grant of any right (including without limitation any put or call
option) with respect to the Common Stock or with respect to any security (other than a broad-based market basket or index) that
includes, relates to or derives any significant part of its value from the Common Stock.

 

(F) Acknowledgment Regarding Investor’s Purchase of
Shares. The Investor is acting solely in the capacity of arm’s length purchaser with respect to this Agreement and the
transactions contemplated hereby and thereby and as of the date hereof, (i) the Investor is not an “affiliate” of
the Company (as defined in Rule 144), and (ii) the Investor is not a “beneficial owner” of more than 10% of the shares
of Common Stock (as defined for purposes of Rule 13d-3 of the Exchange Act). Neither the Investor nor any of its affiliates (as
such term is defined below) own any Common Stock or other securities of the Company except for: 1,578,647 shares of Common Stock.

 

(G) Further Representations by Foreign Investors. If
the Investor is not a United States person, the Investor hereby represents and warrants that he or she or it has satisfied himself
or herself or itself as to the full observance of the laws of his or her or its jurisdiction in connection with any commitment,
understanding or agreement to purchase the Shares, including (a) the legal requirements within his jurisdiction for the purchase
of the Shares, (b) any foreign exchange restrictions applicable to such purchase, and (c) any governmental or other consents that
may need to be obtained (other than (i) the Investor Shareholder Approval, (ii) the Securities Filing, and (iii) the Overseas
Investment Filing). The Investor’s purchase and payment for, and its continued beneficial ownership of the Shares, will
not violate any applicable securities or other laws of his or her or its jurisdiction. No governmental authority or affiliate
of any governmental authority has any direct or indirect ownership or other beneficial interest in Investor or will have any direct
or indirect ownership or other beneficial interest in the Shares.

 

3. Representations
and Warranties of the Company. The Company represents and warrants as follows:

 

(A) Organization Form. The Company is a corporation
duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite power and
authority to own or lease and operate its properties and to carry on its business as now conducted and described in the SEC Reports
(as defined below).

 

(B) Authority. The Company has all requisite power and
authority to enter into and perform all of its obligations under this Agreement and to carry out the transactions contemplated
hereby, including all requisite power and authority to issue the Shares. The Shares, when issued, delivered and paid for in accordance
with the terms hereof, will be duly and validly issued, fully paid and non-assessable and free and clear of any mortgage, pledge,
security interest, encumbrance, deposit agreement, lien (statutory or otherwise) or charge of any kind (including any agreement
to give any of the foregoing, any conditional sale or other title retention agreement). The holders of outstanding shares of Common
Stock are not entitled to statutory, preemptive or other similar contractual rights to subscribe for shares of Common Stock; and
no options, warrants or other rights to purchase, agreements or other obligations to issue, or rights to convert any obligations
into or exchange any securities for, securities of the Company or equity interests in the Company are outstanding except as described
in the Company’s SEC Reports. The term “SEC Reports” means all documents and other materials including
the exhibits thereto and documents incorporated by reference therein, filed by the Company or on its behalf under the Exchange
Act.

 

    	 	3	 

     

    

 

(C) Actions Authorized. The Company has taken all corporate
actions necessary to authorize it to enter into and perform its obligations under this Agreement and to consummate the transactions
contemplated hereby.

 

(D) Due Execution and Delivery. The Company has duly
executed and delivered this Agreement and the Company has executed, or will execute, and the Registration Rights Agreement; this
Agreement constitutes a legal, valid and binding obligation of the Company and, when executed, the Registration Rights Agreement
will constitute legal, valid and binding obligations of the Company, each enforceable in accordance with their respective terms;
and no consent, approval, authorization, order, filing, registration or qualification of or with any court, governmental authority
or third person is required to be obtained by the Company in connection with the execution and delivery of this Agreement, or
by the Company, other than the receipt by the Board of a satisfactory background check regarding the Nominee (the “Director
Background Condition”), and filing by the Company of 15 days’ prior notice to the NASDAQ Stock Market of the issuance
of the Shares, in connection with the execution and delivery of the Registration Rights Agreement or the performance of the Company's
obligations hereunder or thereunder. The Company will give prompt notice to Investor when the Director Background Check is satisfied.

 

(E) No Conflicts.
Neither the execution, delivery or performance of this Agreement nor the consummation of the transactions contemplated hereby by
the Company will conflict with the (i) certificate of incorporation or by-laws of the Company, (ii) any federal, state, local or
foreign order, writ, injunction, judgment, settlement, award, decree, statute, law, rule or regulation applicable to the Company
or its subsidiaries or injunction of any court, regulatory body, administrative agency, governmental body, arbitrator or other
authority having jurisdiction over the Company or any of its subsidiaries or (iii) result in any breach of, or constitute a default
under any contract, agreement or instrument to which the Company is a party or by which it or any of its assets is bound, except
in the case of clauses (ii) and (iii) for such conflict, breach, violation or default that would not reasonably be expected to
have, individually or in the aggregate, a material adverse effect on the condition (financial or otherwise), results of operations,
business, properties, management, consolidated financial position, stockholders’ equity or prospects of the Company and its
subsidiaries taken as a whole or the ability of the Company to consummate the transactions contemplated by this Agreement on a
timely basis (a “Material Adverse Effect”).

 

(F) NASDAQ Stock
Market Compliance. The Common Stock is registered pursuant to Section 12(b) or Section 12(g) of the United States Securities
and Exchange Act of 1934 (the “Exchange Act”) and is listed or quoted on the NASDAQ Global Select Market (the
“Principal Market”), and the Company has taken no action designed to, or likely to have the effect of, terminating
the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Principal Market, nor has the
Company received any notification that the United States Securities and Exchange Commission (the “SEC”) or the
Principal Market is contemplating terminating such registration or listing.

 

    	 	4	 

     

    

 

(G) SEC Reports. The Company has filed in a timely manner
all SEC Reports that the Company was required to file under the Exchange Act during the 36 months preceding the date of this Agreement.

 

(H) Compliance with Law. The Company and its subsidiaries
and all of their respective properties and facilities are in compliance in all material respects with all foreign, federal, state,
local and regional statutes, laws, ordinances and judicial or administrative orders, judgments, rulings and regulations, except,
in any case, where failure to comply could not reasonably be expected to have a Material Adverse Effect.

 

(I) Capitalization. The authorized equity capitalization
of the Company is as set forth in the SEC Reports; as of the date of this Agreement, prior to the issuance and sale of the Shares,
as contemplated hereby, the issued and outstanding shares of Common Stock is 23,208,535 and 6,258,985 shares of Common Stock are
issuable upon conversion of the Company’s 2018 convertible senior notes, 11,725,027 shares of Common Stock are issuable
upon conversion of the Company’s 2020 convertible senior notes, and 1,500,000 shares of Common Stock are issuable upon exercise
of the Company’s outstanding warrants, 1,011,109 shares of Common Stock are issuable under restricted stock agreements between
the Company and certain executives and employees, and no other equity shares are issuable upon conversion, exchange or exercise
of outstanding securities, options or other agreements.

 

(J) Private Placement.
Assuming the accuracy of the Investor’s representations and warranties set forth in Section 2 of this Agreement (i) no registration
under the Securities Act is required for the offer and sale of the Shares by the Company to the Investor hereunder, and (ii) the
issuance and sale of the Shares hereunder does not contravene the rules and regulations of the Nasdaq Stock Market.

 

4. Governance.

 

(A) On the Closing
Date, the size of the Board shall be increased from six (6) members to seven (7) members and the vacancy created by the increase
in the size of the Board shall be filled by the Nominee. The parties agree that the Nominee is entitled to bring an interpreter
for all board meetings that he is attending, provided that the interpreter executes a confidentiality agreement required by the
Board and does not interfere with the conduct of the meeting and provided that the interpreter’s presence at the meeting
does not impair the attorney client privilege with respect to communications made by the Company’s attorney to the Board.
As long as the Investor and its affiliates hold 10% or more of the issued and outstanding shares of Common Stock of the Company,
the Investor shall have the right from time to time to designate a nominee (who shall be Mr. Xiaoqiang Zhao) for election to the
Board.

 

    	 	5	 

     

    

 

(B) As long as the
Investor and its affiliates hold 10% or more of the issued and outstanding shares of Common Stock of the Company, the Company shall
cause the Board to (x) name the Nominee as a nominee for election as a director of the Company at each annual meeting of its shareholders
(an “Annual Meeting”) in its definitive proxy statements to be filed with the Securities and Exchange Commission
(the “SEC”) in connection therewith and (y) recommend that the stockholders of the Company vote to elect the
Nominee as a director of the Company at each Annual Meeting; and the Company shall use its reasonable best efforts (which shall
include the solicitation of proxies) to obtain the election of the Nominee at each Annual Meeting (it being understood that such
efforts shall be not less than the efforts used by the Company to obtain the election of any non-employee director nominee nominated
by it to serve as a director on the Board at such Annual Meetings), provided that the Nominee in the judgment of the other members
of the Board continues to meet the general standards applicable to all directors.

 

(C) The Board may nominate
up to eight (8) individuals (including the Nominee) for election at each Annual Meeting and such additional individuals necessary
so that a majority of the members of the Board qualify as independent as such term is defined in the rules of the Principal Market.
As long as the Investor and its affiliates hold 10% or more of the issued and outstanding shares of Common Stock of the Company,
without the approval of the Investor, the Company shall not increase the size of the Board in excess of eight (8) members, and
such additional individuals necessary so that a majority of the members of the Board qualify as independent, and shall not decrease
the size of the Board if such decrease would require the resignation of the Nominee.

 

(D) The Company shall
take or cause to be taken all lawful action necessary to ensure at all times that the Company’s certificate of incorporation,
bylaws and any other governance documents are not at any time inconsistent with the provisions of this Section 4.

 

(E) From the date of
this Agreement and so long as the Investor is entitled to nominate a director pursuant to this Agreement and the Nominee is actually
elected as a director of the Company (such period, the “Cooperation Period”) unless the Nominee is not elected
as a result of his resignation or death in which case the Cooperation Period shall continue for the period that the Investor and
its affiliates hold 10% or more of the issued and outstanding shares of Common Stock of the Company, the Investor shall cause all
Voting Securities (as defined below) that it and its affiliates are entitled to vote at each Annual Meeting (whether held of record
or beneficially) to be present for quorum purposes and to be voted in favor of the election of each of the Board's incumbent nominees
and the additional nominee(s) referred to in paragraph 4(C) hereof, if any is proposed by the Company, for election as a director.

 

(F) During the Cooperation
Period, without the approval of the Board, the Investor shall not and shall cause its affiliates, associates and Representatives
(as such terms are defined below) not to:

 

i. effect
or seek, offer or propose (whether publicly or otherwise) to effect, or announce any intention to effect or cause or participate
in or in any way assist, facilitate or encourage any other individual, general or limited partnership, corporation, limited liability
or unlimited liability company, joint venture, estate, trust, group, association or other entity of any kind or structure (collectively,
a "Person") to effect or seek, offer or propose (whether publicly or otherwise) to effect or participate in, any
"solicitation" of "proxies" (as such terms are used in the proxy rules of the SEC) to vote any Voting Securities
of the Company or consent to any action from any holder of any Voting Securities of the Company or conduct or suggest any binding
or nonbinding referendum or resolution or seek to advise, encourage or influence any Person with respect to the voting of or the
granting of any consent with respect to any Voting Securities of the Company; provided, however, that the foregoing shall not in
any way limit the ability of the Investor, or any of its affiliates, to vote or tender any Voting Securities pursuant to any solicitation
by a third party, subject to the provisions of Section 4(F) hereof or any solicitation in respect of voting for election of directors
pursuant to this Section 4;

 

    	 	6	 

     

    

 

ii. propose
(except for the Nominee) or nominate, or cause or encourage any Person to propose or nominate, any candidates to stand for election
to the Board, or seek the removal of any member (except for the Nominee) of the Board;

  

iii. form,
join or otherwise participate in any "partnership, limited partnership, syndicate or other group" (other than any group
among some or all of the affiliates of Investor) within the meaning of Section 13(d)(3) of the Exchange Act (as such term is defined
below) with respect to the Common Stock, or deposit any shares of Common Stock in a voting trust or similar arrangement, or subject
any shares of Common Stock to any voting agreement or pooling arrangement, or grant any proxy with respect to any shares of Common
Stock (other than to a designated representative of the Company pursuant to a proxy statement of the Company) or otherwise act
in concert with any Person with respect to the Common Stock (other than affiliates of Investor);

  

iv. otherwise
publicly act, alone or in concert with others, to control or seek to control, to seek representation on, or to influence or seek
to influence, whether through litigation or otherwise, the management, the Board or the policies of the Company; provided, however,
that nothing herein shall prohibit (i) the Investor from complying with legal or regulatory requirements, including, without limitation,
the filing of any report or schedule required to be filed with the SEC, or (ii) the Nominee to exercise its rights or discharge
its obligations as a director of the Company; provided, further, that the Investor, acting alone, may privately communicate its
views to members of the Company's management team or to members of the Board; or

 

v. otherwise
take, or solicit, cause or encourage others to take, any action inconsistent with any of the foregoing.

 

vi. Notwithstanding
anything in this Agreement to the contrary, nothing in this Section 4(F) shall be deemed to in any way restrict or otherwise limit
the Nominee from (i) performing his fiduciary duties as a director of the Company, once elected, or (ii) exercising his rights
as a director of the Company, once elected.

  

(G) D&O Insurance.
The Company shall procure that the Nominee shall be entitled to indemnification arrangements and director and officer insurance
coverage equivalent to such arrangements and insurance coverage applicable to all non-employee directors of the Company or to which
all non-employee directors of the Company are entitled to receive.

 

    	 	7	 

     

    

 

(H)Definitions.For purposes of this Agreement:

 

i. the terms
“affiliate” and “associate” shall have the respective meanings set forth in Rule 12b-2 promulgated
by the SEC under the Securities Exchange Act of 1934, as amended (the “Exchange Act”);

 

ii. the
terms “beneficial owner” and “beneficially own” shall have the same meanings as set forth
in Rule 13d-3 promulgated by the SEC under the Exchange Act except that a Person shall also be deemed to be the beneficial owner
of all shares of Common Stock which such person has the right to acquire (whether such right is exercisable immediately or only
after the passage of time) pursuant to the exercise of any rights in connection with any securities or any agreement, arrangement
or understanding (whether or not in writing), regardless of when such rights may be exercised and whether they are conditional,
and all shares of Common Stock which such Person or any of such Person’s affiliates or associates has or shares the right
to vote or dispose;

 

iii. the
term “Representatives” shall mean, with respect to any Person, such Person's officers, directors, members, general
partners, employees, counsel and financial advisors; and

 

iv.  the
term "Voting Securities" shall mean the shares of the Company's Common Stock and any other securities of the Company
entitled to vote in the election of directors, or securities convertible into, or exercisable or exchangeable for, the Common Stock
or such other securities, whether or not subject to the passage of time or other contingencies.

 

5. Miscellaneous.

 

(A) Binding Effect.
This Agreement shall be binding upon and inure to the benefit of the parties to this Agreement and their respective successors
and permitted assigns. Nothing in this Agreement, express or implied, is intended or shall be construed to give any person other
than the parties to this Agreement and their respective successors or permitted assigns any legal or equitable right, remedy or
claim under or in respect of any agreement or any provision contained herein.

 

(B) Waiver. Either party hereto may by written notice
to the other (i) extend the time for the performance of any of the obligations or other actions of the other party under this
Agreement; (ii) waive compliance with any of the conditions or covenants of the other party contained in this Agreement; and (iii)
waive or modify performance of any of the obligations of the other party under this Agreement. Except as provided in the preceding
sentence, no action taken pursuant to this Agreement, including, without limitation, any investigation by or on behalf of either
party, shall be deemed to constitute a waiver by the party taking such action of compliance with any representations, warranties,
covenants or agreements contained herein. The waiver by either party hereto of a breach of any provision of this Agreement shall
not operate or be construed as a waiver of any preceding or succeeding breach and no failure by either party to exercise any right
or privilege hereunder shall be deemed a waiver of such party's rights or privileges hereunder or shall be deemed a waiver of
such party's rights to exercise the same at any subsequent time or times hereunder.

 

(C) Disclosure of Transaction. The Company shall issue
a press release and file a current report on Form 8-K with the SEC, describing the transactions contemplated by this Agreement,
and provide a copy of the proposed press release and Form 8-K to the Investor in advance of issuance or filing, as the case may
be, on or before 9:00 a.m., New York City time, on the second business day following entry into this agreement. The parties hereto
acknowledge, confirm and agree that each party (or its parent company) shall be entitled, without the prior approval of the other
party, to make any press release or other public disclosure with respect to the transactions contemplated hereby as is required
by applicable law, regulations and stock exchange rules.

 

    	 	8	 

     

    

 

(D) Notices. All notices and other communications given
or made pursuant hereto shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to
be notified, (b) when sent by confirmed facsimile or e-mail if sent during normal business hours of the recipient; if not, then
on the next business day, (c) five (5) days after deposit with an internationally recognized courier with written verification
of receipt. All communications shall be sent to the Company and to the Investor at the addresses for the Company and the Investor
on the counterpart signature page(s) hereto (or at such other addresses as shall be specified by notice given in accordance with
this Section.

 

(E) Amendments. Neither this Agreement nor any term
or provision hereof may be amended, modified, waived or supplemented orally, but only by a written instrument executed by the
parties hereto.

 

(F) Assignability.
Neither this Agreement nor any right, remedy, obligation or liability arising hereunder or by reason hereof shall be assignable
by either the Company or the Investor without the prior written consent of the other party.

 

(G) Applicable Law.
This Agreement shall be governed by and construed in accordance with the law of the State of Delaware, United States of America,
regardless of the law that might be applied under principles of conflicts of law.

 

(H) Entire Agreement.
This Agreement and the Registration Rights Agreement constitute the entire agreement between the parties with respect to the subject
matter hereof and thereof and no party shall be liable or bound to any other party in any manner by any warranties, representations,
or covenants except as specifically set forth herein or therein.

 

(I) Counterparts.
This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute
one and the same instrument. This Agreement and any counterpart hereof may be executed and delivered by facsimile copies or executed
and delivered by electronic communications by portable document format (.pdf), each of which shall be deemed an original.

 

(J) Section Headings.
The section headings used in this Agreement are used for convenience only and are not to be considered in construing or interpreting
this Agreement.

 

[Signature pages follow]

 

    	 	9	 

     

    

  

IN WITNESS WHEREOF, the parties hereto have executed this Agreement
as of the date first above written.

 

	 	COMPANY:	 
	 	 	 	 
	 	JAKKS Pacific, Inc.	 
	 	 	 	 
	 	By:	 	 
	 	 	 	 
	 	Name:	 	 
	 	 	 	 
	 	Address:  	2951 28th Street	 
	  	 	Santa Monica, CA 90405	 

  

    	 	10	 

     

    

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement
as of the date first above written.

 

	 	INVESTOR:	 
	 	 	 	 
	 	Hongkong Meisheng Culture Company Ltd.	 
	 	 	 
	 	By: 	 	 
	 	 	 	 
	 	Name: 	 	 
	 	 	 	 
	 	Address: 	 	 
	 	 	 	 
	 	 	 	 

  

    	 	11	 

     

    

 

EXHIBIT

 

 

FORM OF REGISTRATION RIGHTS AGREEMENT

 

 

(Attached)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00268-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00268-of-00352.parquet"}]]